The cystic fibrosis treatment leader exceeded revenue expectations, but missed slightly on earnings per share.

Q1 2025 Management View CEO Blake Moret highlighted operational efficiency and cost control initiatives, projecting $250 million in productivity benefits for fiscal 2025. He confirmed mitigation plans ...

Reports Q4 revenue $252.4M, consensus $244.95M. President and CEO Russell Low commented, “Axcelis (ACLS) exited the year on a strong note, with ...

ConocoPhillips (NYSE:COP) shares are trading higher after the company released fourth-quarter results. Here’s a breakdown of ...

Walt Disney surprised analysts with a strong first-quarter performance, driven by an uptick in its direct-to-consumer segment ...

Cloudflare reported earnings that not only beat analyst estimates but also exceeded its own forecasts, highlighting robust ...

Incyte says 2025 is expected to be a year of defining catalysts with four launches, four pivotal study readouts, at least ...

Yum China Holdings, Inc. (NYSE:YUMC) shares are trading higher on Thursday after the fourth-quarter FY24 earnings result. The ...

Kemper's strategic exit from insurance boosts FCF growth through 2031. See why KMPR stock’s strong repurchase plan enhances demand and stock price.

Shares of Amgen (AMGN) fell in after-hours trading after the biotechnology company reported earnings for its fourth quarter ...

Snapchat (SNAP) reported its Q4 2024 earnings results today, posting beats on both earnings per share (EPS) and revenue ...

AMD’s Q4 2024 earnings report was released at the close of markets today. The tech company reported $7.7 billion in revenue, ...